Mon, October 9, 2023
Fri, October 6, 2023
Thu, October 5, 2023
Wed, October 4, 2023
Tue, October 3, 2023

Michael Okunewitch Initiated (ACRV) at Strong Buy and Held Target at $24 on, Oct 5th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-24-on-oct-5th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Michael Okunewitch of Maxim Group, Initiated "Acrivon Therapeutics, Inc." (ACRV) at Strong Buy and Held Target at $24 on, Oct 5th, 2023.

Michael has made no other calls on ACRV in the last 4 months.



There are 2 other peers that have a rating on ACRV. Out of the 2 peers that are also analyzing ACRV, 0 agree with Michael's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Michael


  • Emily Bodnar of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Wednesday, September 6th, 2023
  • Soumit Roy of "JonesTrading" Initiated at Strong Buy and Held Target at $26 on, Friday, August 18th, 2023

Publication Contributing Sources